CSIMarket
 
Tff Pharmaceuticals Inc   (TFFP)
Other Ticker:  
 
 

Tff Pharmaceuticals Inc's Customers Performance

TFFP

 
TFFP's Source of Revenues During the corresponding time, Tff Pharmaceuticals Inc sequentially revenue fell by -29.57 %. While revenue at the Tff Pharmaceuticals Inc 's corporate clients

List of TFFP Customers




for the same period Tff Pharmaceuticals Inc sequentially revnue fell by -29.57 %.

List of TFFP Customers




Tff Pharmaceuticals Inc's Comment on Sales, Marketing and Customers





  News about Tff Pharmaceuticals Inc Contracts

Prioritizing the Clinical Development of Tacrolimus Inhalation Powder: A Promising Solution for Lung Transplantation

In the world of pharmaceutical sciences, continuous research and clinical development efforts are paramount. TFF Pharmaceuticals, a renowned pharmaceutical company, has recently announced an important update on their clinical programs. This article aims to interpret and highlight the key facts from their announcement, as well as assess the potential impact on the company. TFF Pharmaceuticals has made a significant decision to prioritize the clinical development of Tacrolimus Inhalation Powder (TFF TAC) based on positive Phase 2 data. This decision stems from the recognition of a significant unmet need in lung transplant medicine and a substantial market opportunity. The company's latest announcement has draw...

TFF Pharmaceuticals Unveils Triumphs: Groundbreaking Phase 2 Trial Results Set to Revolutionize Drug Delivery

TFF Pharmaceuticals: Unveiling Promising Phase 2 Trial Results for TFF VORI and TFF TAC
TFF Pharmaceuticals, a cutting-edge pharmaceutical company at the forefront of novel drug delivery solutions, is scheduled to host an eagerly anticipated webcast and conference call on Tuesday, December 19th at 8:30 am ET. The purpose of this highly anticipated event is to unveil the initial data from the ongoing Phase 2 trials of TFF VORI and TFF TAC, two ground-breaking drug candidates with immense potential in the field of pharmacotherapy.
This announcement follows the company's recent achievement in successfully completing the first stage of these pivotal clinical trials. With Phase 2 trials defining a signif...












TFFP's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Tff Pharmaceuticals Inc 307.90 0.97 -13.70 -
SUBTOTAL 0.00 0.00 0.00 -


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com